-
A4805-5 mg
Thomas Scientific
Aminopeptidase inhibitor that also induces vasoconstriction. (C08-0489-206)
Price: $391.50List Price: $435.00Amastatin inhibits enzymatic activity of aminopeptidases in vivo and in vitro it also exhibits vasoconstrictive/pressor activity. -
A4805-10 mg
Thomas Scientific
Aminopeptidase inhibitor that also induces vasoconstriction. (C08-0489-524)
Price: $641.73List Price: $713.03Amastatin inhibits enzymatic activity of aminopeptidases in vivo and in vitro it also exhibits vasoconstrictive/pressor activity. -
15213-1A class III antiarrhythmic agent inhibits KCNH2 with an IC<sub>50</sub> value of 1 µM also inhibits CYP2C8 and CYP3A4 in vitro at low micromolar concentrations.
-
15213-10A class III antiarrhythmic agent inhibits KCNH2 with an IC<sub>50</sub> value of 1 µM also inhibits CYP2C8 and CYP3A4 in vitro at low micromolar concentrations.
-
15213-5A class III antiarrhythmic agent inhibits KCNH2 with an IC<sub>50</sub> value of 1 µM also inhibits CYP2C8 and CYP3A4 in vitro at low micromolar concentrations.
-
15213-500A class III antiarrhythmic agent inhibits KCNH2 with an IC<sub>50</sub> value of 1 µM also inhibits CYP2C8 and CYP3A4 in vitro at low micromolar concentrations.
-
14619-100A potent antagonist of the dopamine receptors D2 and D3 (Ki = 2.8 and 3.2 nM, respectively, for the human receptors) also shown to be a potent antagonist of the serotonin receptors 5-HT2B and 5-HT7 (Ki = 13, 11.5 nM, respectively).
-
14619-25A potent antagonist of the dopamine receptors D2 and D3 (Ki = 2.8 and 3.2 nM, respectively, for the human receptors) also shown to be a potent antagonist of the serotonin receptors 5-HT2B and 5-HT7 (Ki = 13, 11.5 nM, respectively).
-
14619-50A potent antagonist of the dopamine receptors D2 and D3 (Ki = 2.8 and 3.2 nM, respectively, for the human receptors) also shown to be a potent antagonist of the serotonin receptors 5-HT2B and 5-HT7 (Ki = 13, 11.5 nM, respectively).
-
14619-500A potent antagonist of the dopamine receptors D2 and D3 (Ki = 2.8 and 3.2 nM, respectively, for the human receptors) also shown to be a potent antagonist of the serotonin receptors 5-HT2B and 5-HT7 (Ki = 13, 11.5 nM, respectively).
-
15881-10A first generation tricyclic antidepressant blocks the serotonin and norepinephrine transporters (Kds = 4.3 and 35 nM, respectively) inhibits 5-HT2A receptor (Ki =20 nM) antagonizes histamine H1, muscarinic acetylcholine, and &alpha1-adrenergic
-
15881-25A first generation tricyclic antidepressant blocks the serotonin and norepinephrine transporters (Kds = 4.3 and 35 nM, respectively) inhibits 5-HT2A receptor (Ki =20 nM) antagonizes histamine H1, muscarinic acetylcholine, and &alpha1-adrenergic